A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions

Metabolism: Clinical and Experimental

Volumn 54, Issue 5, 2005, Pages 573-578

  Yotsumoto, Takashi ^a   Naitoh, Takeshi ^a   Kanaki, Tatsuro ^a   Tsuruzoe, Nobutomo ^a  

^a NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2,3 (2,5 DIMETHYL 2,5 HEXANO) 5 METHYL 8 NITRODIBENZO[B,E][1,4]DIAZEPIN 11 YL]BENZOIC ACID; BENZOIC ACID DERIVATIVE; HK 531; LEPTIN; RECEPTOR BLOCKING AGENT; RETINOID X RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FAT CONTENT; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE RESISTANCE; HORMONE SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

EID: 17844394150     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.11.013     Document Type: Article

References (18)

1. J.L. Halaas, K.S. Gajiwala, and M. Maffei Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543 546
2. M.A. Pelleymounter, M.J. Cullen, and M.B. Baker Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 1995 475 476
3. L.A. Campfield, F.J. Smith, and Y. Guisez Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks Science 269 1995 546 549
4. R.C. Frederich, A. Hamann, and S. Anderson Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action Nat. Med. 1 1995 1311 1314
5. M. Maffei, J. Halaas, and E. Ravussin Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat. Med. 1 1995 1155 1161
6. R.V. Considine, M.K. Sinha, and M.L. Heiman Serum immunoreactive-leptin concentrations in normal-weight and obese humans N. Engl. J. Med. 334 1996 292 295
7. J.F. Caro, J.W. Kolaczynski, and M.R. Nyce Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance Lancet 348 1996 159 161
8. M.W. Schwarts, E. Peskind, and M. Raskind Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans Nat. Med. 2 1996 589 593
9. J.L. Halaas, C. Boozer, and J. Blair-West Physiological response to long-term peripheral and central leptin infusion in lean and obese mice Proc. Natl. Acad. Sci. U S A 94 1997 8878 8883
10. H. Masuzaki, Y. Ogawa, and M. Aizawa-Abe Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation. Usefulness of leptin for the treatment of obesity-associated diabetes Diabetes 48 1999 1615 1622
11. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
12. A.R. Saltiel, and J.M. Olefsky Thiazolidinediones in the treatment of insulin resistance and type II diabetes Diabetes 45 1996 1661 1669
13. J. Auwerx PPAR gamma, the ultimate thrifty gene Diabetologia 42 1999 1033 1049
14. J.M. Lehmann, L.B. Moore, and T.A. Smith-Oliver An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators- activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
15. R. Mukherjee, P.J. Davies, and D.L. Crombie Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists Nature 386 1997 407 410
16. M. Ebihara, H. Umemiya, and K. Ohta Retinoid X receptor-antagonistic diazepinylbenzoic acids Chem. Pharm. Bull. 47 1999 1778 1786
17. T. Yamauchi, H. Waki, and J. Kamon Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes J. Clin. Invest. 108 2001 1001 1013
18. K. Ebihara, Y. Ogawa, and G. Katsuura Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action Diabetes 48 1999 2028 2033